Related Experiment Video
Updated: Jul 15, 2026
07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
Anaphylaxis: evidence-based long-term risk reduction in the community
1Department of Pediatrics & Child Health, Department of Immunology, Canadian Institutes of Health Research National Training Program in Allergy and Asthma, University of Manitoba, 820 Sherbrook Street, Winnipeg, MB, R3A 1R9, Canada. lmcniven@hsc.mb.ca
Immunology and Allergy Clinics of North America
|May 12, 2007
Summary
Anaphylaxis, a severe allergic reaction, requires expert-led risk assessment and reduction strategies. Key elements include trigger avoidance, emergency preparedness with epinephrine, and comprehensive education for all involved.
Area of Science:
- Allergy and Immunology
- Public Health
Background:
- Anaphylaxis is a common and potentially fatal allergic reaction occurring in community settings.
- Effective management necessitates a coordinated approach by allergy/immunology specialists.
Purpose of the Study:
- To outline essential components for anaphylaxis risk assessment and reduction.
- To emphasize strategies for preventing recurrent episodes and ensuring emergency preparedness.
Main Methods:
- Focus on trigger avoidance, specific preventive measures, and comorbidity management.
- Highlight emergency preparedness including self-injectable epinephrine and action plans.
- Stress the importance of personalized Anaphylaxis Emergency Action Plans and medical identification.
Main Results:
- Recurrent anaphylaxis episodes can occur despite avoidance efforts.
- Comprehensive risk reduction involves both prevention and preparedness.
- Education for patients, families, healthcare professionals, and the public is crucial.
Conclusions:
- Anaphylaxis management requires a multi-faceted approach coordinated by specialists.
- Emergency preparedness, including accessible epinephrine and clear action plans, is vital.
- Ongoing education is essential for individuals, families, and healthcare providers to mitigate anaphylaxis risks.
Related Concept Videos
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
02:06Allergic Reactions
Overview
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:30Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...